All You Need to Know About AcelRx Pharmaceuticals (ACRX) Rating Upgrade to BuyZacks Investment Research • 05/08/20
AcelRx Pharmaceuticals (ACRX) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 05/06/20
AcelRx Acquiring Tetraphase, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 03/17/20
AcelRx Pharmaceuticals, Inc.'s (ACRX) CEO Vince Angotti on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/16/20
Earnings Preview: AcelRx Pharmaceuticals (ACRX) Q4 Earnings Expected to DeclineZacks Investment Research • 02/27/20
AcelRx Pharmaceuticals (ACRX) Stock Moves -1.14%: What You Should KnowZacks Investment Research • 01/27/20
AcelRx Pharmaceuticals (ACRX) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 01/13/20
AcelRx Pharmaceuticals (ACRX) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 01/03/20
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vince Angotti on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Earnings Preview: AcelRx Pharmaceuticals (ACRX) Q3 Earnings Expected to DeclineZacks Investment Research • 10/30/19
Analysts Estimate AcelRx Pharmaceuticals (ACRX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/25/19